News
Check out the latest developments as we transform patient care through genomic monitoring from home.
October, 2022
Rigorous audit validates DxTerity Platforms for Diagnostic and Clinical Data as a trusted laboratory and data partner for clinical health care delivery to physicians, patients, and pharmaceuti [...]
June, 2022
New test aims to identify patients that may benefit from precision treatment
Los Angeles, CA., June XX, 2022 – DxTerity Diagnostics today announced the commercial launch of the [...]
May 18, 2022
Journey's Commitment to Global Security Standards and Adherence to Industry Best Practices in Implementing Data Privacy Controls Builds Stronger Trust and More Secure Interactions Between Busine [...]
November 5, 2021
On the heels of the November 5, 2021 updated guidelines from Occupational Safety and Health Administration (OSHA), DxTerity Diagnostics announces SafeWorkDx™ facilitates employee self-coll [...]
October 28, 2020
COVID-19 Testing Industry Consortium
COVID-19 Testing Industry Consortium releases a guide to addressing the complexities of this pandemic. The COVID-19 Testing Industry Consortium brings together a div [...]
October 21, 2020
SafeWorkDx is the only saliva-based test that is EUA authorized for screening at home.
(Los Angeles, CA) – DxTerity Diagnostics announced the FDA Emergency Use Authoriza [...]
March 26, 2020
(Los Angeles, CA) – DxTerity Diagnostics announced today that it is developing a business enterprise solution to assist in making the workplace safer in a COVID-19 world. The “KEEP AMERICA WORKING” subscription service is [...]
March 3, 2020
DxTerity device enables from home, gene expression monitoring of patients
LOS ANGELES, CA – February 27, 2020 – DxTerity Diagnostics has declared conformity with the requirements of the European I [...]
February 3, 2020
Eyes Clinical Adoption of IFN-1 and MIP testing
LOS ANGELES, CA – January 6, 2019 – DxTerity Diagnostics Inc. has announced the hiring of Brett Swansiger for the position of CCO – Chief Commercial [...]
November 8, 2019
LabPulse also featured the news this morning, as scheduled:
November 8, 2019 -- California-based [...]
DxTerity® Brings Precision Medicine to Systemic Lupus Erythematosus (SLE)
Along with the release of new Longitudinal SLE Clinical Study Results, the [...]
Eyes global delivery of Modular Immune Profile (MIP) Assay for Autoimmune Disease
LOS ANGELES, CA – November 8, 2019 – DxTerity Diagnostics Inc. has announced the signing of a [...]
October 29, 2019
Genome Web
DxTerity Diagnostics has launched the IFN-1 Test for determining a systemic lupus erythematosus patient's type 1 interferon status and the [...]
Better health management begins at home
Subscribe to receive the latest information on new developments and products at DxTerity.